Response to Wang et al. Re: How to choose and compare between radiofrequency ablation and transarterial chemoembolization for recurrent hepatocellular carcinoma?

Koh PS 1 , Chan AC 2

Affiliations 

  • 1 Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: kohps2000@yahoo.com
  • 2 Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
HPB (Oxford), 2017 12;19(12):1133.
PMID: 28943394 DOI: 10.1016/j.hpb.2017.08.007

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications